The omicron variant of the novel coronavirus is seen in an electron micrograph.
13:52 JST, July 15, 2022
About 10.02 million people in Japan have been infected with the novel coronavirus since the country’s first case was confirmed in January 2020, according to a tally compiled Thursday by The Yomiuri Shimbun.
The rate of increase continues to rise rapidly, driven by the virus’s highly contagious omicron strain: More than 8 million cases have occurred since January alone, during the sixth and the seventh waves of the pandemic.
More than 2 million people had been infected as of Jan. 20, with case numbers rising to around 5 million by Feb. 28. Thereafter, the rate of increase slowed for a while, but began to climb again in July due to the spread of the potent BA.5 omicron variant.
By prefecture, Tokyo has registered about 1.71 million cases, Osaka Prefecture about 1.08 million and Kanagawa Prefecture about 0.83 million.
Some 97,788 new cases were confirmed Thursday, with 16,662 occurring in Tokyo, 216 fewer than the previous day, but twice as many as the same day a week before and marking the 27th consecutive day of week-on-week increases.
A record number of new cases were observed on the day in nine prefectures — Aomori, Shizuoka, Mie, Yamaguchi, Kagawa, Fukuoka, Nagasaki, Kumamoto and Okinawa.
Top Articles in Society
-
Producer Behind Pop Group XG Arrested for Cocaine Possession
-
Man Infected with Measles Reportedly Dined at Restaurant in Tokyo Station
-
15 Measles Patients Confirmed in Tokyo in Past 6 Days; 1 May Have Come into Contact with Many in Shibuya
-
Bus Carrying 40 Passengers Catches Fire on Chuo Expressway; All Evacuate Safely
-
Ibaraki Pref.’s 1st Foreign Bus Driver Hired in Tsukuba
JN ACCESS RANKING
-
Producer Behind Pop Group XG Arrested for Cocaine Possession
-
Japan PM Takaichi’s Cabinet Resigns en Masse
-
Man Infected with Measles Reportedly Dined at Restaurant in Tokyo Station
-
Japan Figure Skating Legend Yuzuru Hanyu Is Proud Disaster Survivor and Gold Medalist, Vows to Continue Support Efforts
-
iPS Treatments Pass Key Milestone, but Broader Applications Far from Guaranteed

